title: Treatment of progressive brain stem glioma with bevacizumab: radiological, metabolic and histopathological aspects.
authors: University Hospital Freiburg, Department of Stereotactic and Functional Neurosurgery, Freiburg, Germany. thomas.reithmeier@uniklinik-freiburg.de
authors: T
authors: T
authors: Reithmeier
authors: C
authors: C
authors: Rottenburger
authors: S
authors: S
authors: Doostkam
authors: M O
authors: MO
authors: Pinsker
authors: M
authors: M
authors: Trippel
authors: B
authors: B
authors: Bosche
authors: W
authors: W
authors: Weber
authors: M
authors: M
authors: Prinz
authors: G
authors: G
authors: Nikkhah
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001254:Astrocytoma / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D000068258:Bevacizumab; D001706:Biopsy; D020295:Brain Stem Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D015254:DNA Modification Methylases / Q000378:metabolism; D045643:DNA Repair Enzymes / Q000378:metabolism; D004244:Dizziness / Q000209:etiology; D005260:Female; D020233:Gait Disorders, Neurologic / Q000209:etiology; D005910:Glioma / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D008967:Molecular Biology; D009325:Nausea / Q000209:etiology; D019635:Neurosurgical Procedures; D049268:Positron-Emission Tomography; D013238:Stereotaxic Techniques; D025521:Tumor Suppressor Proteins / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D025521:Tumor Suppressor Proteins; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes